GlaxoSmithKline | GSK - Receita De Vendas

Preço das Ações
1,928.50
Mudança Diária
10.50 0.55%
Mensal
-6.56%
Anual
31.82%
Q2 Previsão
1,986.06




Vendas Alterar Data
AbbVie USD 15B 1.62B 2026-03
Alcon AG USD 2.7B 110M 2025-12
Almirall EUR 547.63M 12.83M 2025-12
Amgen USD 8.62B 1.28B 2026-03
argenx SE USD 1.12B 132.91M 2025-12
AstraZeneca USD 15.29B 213M 2026-03
Bayer EUR 11.44B 1.78B 2025-12
Biogen USD 2.25B 30M 2026-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Eli Lilly USD 19.8B 500M 2026-03
Fresenius EUR 5.88B 400M 2025-12
Fresenius Medical Care EUR 5.07B 180M 2025-12
Galapagos EUR 900.82M 835.52M 2025-12
Genmab DKK 1.06B 36M 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 7.63B 991M 2026-03
Glaxosmithkline GBP 10.09B 1.37B 2026-03
GRIFOLS EUR 1.98B 110M 2025-12
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Lonza CHF 3.58B 63M 2025-06
Merck EUR 5.25B 70M 2025-12
Merck USD 16.29B 110M 2026-03
Novartis USD 13.11B 226M 2026-03
Novo Nordisk DKK 79.14B 4.16B 2025-12
Orion EUR 417.7M 277.6M 2026-03
Pfizer USD 17.58B 880M 2025-12
Philips EUR 5.1B 797M 2025-12
Recordati EUR 662M 37.65M 2025-12
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.24B 60M 2026-03
Smith & Nephew USD 3.18B 353M 2025-12
UCB EUR 4.25B 764M 2025-12